Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns
Written by
American Journal Managed Care
Published
0
comments
0
min
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.